FDA Adverse Event Injury Summary report: N

S-ICD SYSTEM

MDR report key: 6516752 · Received April 24, 2017

Report

Report Number
2124215-2017-07103
Event Type
Injury
Date Received
April 24, 2017
Date of Event
April 7, 2017
Report Date
April 7, 2017
Manufacturer
CAMERON HEALTH
Product Code
NVY
PMA / PMN Number
P11042
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NL
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4); AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED. REFERENCE: BROUWER, T. F., D. YILMAZ, ET AL. (2016). "LONG-TERM CLINICAL OUTCOMES OF SUBCUTANEOUS VERSUS TRANSVENOUS IMPLANTABLE DEFIBRILLATOR THERAPY." J AM COLL CARDIOL 68(19): 2047-2055.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION FROM A JOURNAL ARTICLE OF A STUDY COMPARING THE LONG-TERM CLINICAL OUTCOMES OF SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (S-ICD) AND TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) THERAPY. DURING THE COURSE OF THE STUDY, SEVERAL DIFFERENT COMPLICATIONS WERE REPORTED THAT OCCURRED WITH THE PATIENTS IMPLANTED WITH S-ICD SYSTEMS: 1 ELECTRODE DISLODGEMENT, 8 INFECTIONS/EROSIONS, 1 DEFIBRILLATION THRESHOLD (DFT) TEST FAILURE, 2 INAPPROPRIATE SENSING, 20 THAT EXPERIENCED INAPPROPRIATE SHOCKS, 1 DEVICE FAILURE, 1 TWIDDLER'S SYNDROME, AND 2 DEATHS. THE SPECIFIC SERIAL NUMBER INFORMATION FOR THE S-ICD DEVICES OR ELECTRODES WAS NOT PROVIDED IN THE ARTICLE AND WAS UNABLE TO BE OBTAINED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
298719 S-ICD SYSTEM IMPLANTABLE LEAD NVY CAMERON HEALTH 3010

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| L| R 1010